EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cell Senescence in Heterotopic Ossification

Robert J Pignolo, Frederick S Kaplan, Haitao Wang iD

Biomolecules · 2024

DOI: 10.3390/biom14040485 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Robert J Pignolo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Geriatric Medicine & Gerontology, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Ossification, Heterotopic, Cellular Senescence, Myositis Ossificans. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Radiant Hope Foundation, The Robert and Arlene Kogod Professorship in Geriatric Medician and Gerontology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The formation of bone outside the normal skeleton, or heterotopic ossification (HO), occurs through genetic and acquired mechanisms. Fibrodysplasia ossificans progressiva (FOP), the most devastating genetic condition of HO, is due to mutations in the ACVR1/ALK2 gene and is relentlessly progressive. Acquired HO is mostly precipitated by injury or orthopedic surgical procedures but can also be associated with certain conditions related to aging. Cellular senescence is a hallmark of aging and thought to be a tumor-suppressive mechanism with characteristic features such as irreversible growth arrest, apoptosis resistance, and an inflammatory senescence-associated secretory phenotype (SASP). Here, we review possible roles for cellular senescence in HO and how targeting senescent cells may provide new therapeutic approaches to both FOP and acquired forms of HO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ossification, HeterotopicCellular SenescenceMyositis OssificansHumansAnimalsActivin Receptors, Type I

Stichwörter der Autor:innen

cellular senescencefibrodysplasia ossificans progressivaheterotopic ossificationsenotherapeutics

Substanzen

Activin Receptors, Type I

Autor:innen und Institutionen

  • Department of Medicine, Section of Geriatric Medicine & Gerontology, Mayo Clinic, Rochester, MN 55905, USA.
  • Divisions of Endocrinology and Hospital Internal Medicine, Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA.
  • Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Orthopaedic Surgery, The Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Department of Medicine, The Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • The Center for Research in FOP and Related Disorders, The Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA 19104, USA.

ORCID-Profile: Haitao Wang

Förderung

  • Radiant Hope Foundation
  • The Robert and Arlene Kogod Professorship in Geriatric Medician and Gerontology

Zitieren

APA

Pignolo, R. J., Kaplan, F. S., & Wang, H. (2024). Cell Senescence in Heterotopic Ossification. Biomolecules. https://doi.org/10.3390/biom14040485

Vancouver

Pignolo RJ, Kaplan FS, Wang H. Cell Senescence in Heterotopic Ossification. Biomolecules. 2024. doi:10.3390/biom14040485

BibTeX
@article{Pignolo2024,
  author = {Pignolo, Robert J and Kaplan, Frederick S and Wang, Haitao},
  title = {Cell Senescence in Heterotopic Ossification},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14040485}
}
Kostenlos starten →